PT1041985E - Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas - Google Patents

Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas

Info

Publication number
PT1041985E
PT1041985E PT98963829T PT98963829T PT1041985E PT 1041985 E PT1041985 E PT 1041985E PT 98963829 T PT98963829 T PT 98963829T PT 98963829 T PT98963829 T PT 98963829T PT 1041985 E PT1041985 E PT 1041985E
Authority
PT
Portugal
Prior art keywords
heptapiridine
benzocyclo
compounds
combination
proliferative diseases
Prior art date
Application number
PT98963829T
Other languages
English (en)
Inventor
Walter R Bishop
Joseph J Catino
Ronald J Doll
Ganguly Ashit
Girijavallabhan Viyyoor
Kirschmeier Paul
Liu Ming
Loretta L Nielsen
David L Cutler
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27385940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1041985(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT1041985E publication Critical patent/PT1041985E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98963829T 1997-12-22 1998-12-21 Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas PT1041985E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99602797A 1997-12-22 1997-12-22
US14352998A 1998-08-28 1998-08-28
US18196998A 1998-10-29 1998-10-29

Publications (1)

Publication Number Publication Date
PT1041985E true PT1041985E (pt) 2006-07-31

Family

ID=27385940

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98963829T PT1041985E (pt) 1997-12-22 1998-12-21 Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas

Country Status (25)

Country Link
EP (1) EP1041985B1 (pt)
JP (1) JP4502503B2 (pt)
KR (1) KR100700907B1 (pt)
CN (1) CN1129431C (pt)
AR (1) AR017440A1 (pt)
AT (1) ATE317697T1 (pt)
AU (1) AU756762B2 (pt)
BR (1) BR9814419A (pt)
CA (1) CA2315693C (pt)
CL (1) CL2007001889A1 (pt)
CO (1) CO5080764A1 (pt)
CZ (1) CZ298511B6 (pt)
DE (1) DE69833509T2 (pt)
DK (1) DK1041985T3 (pt)
ES (1) ES2255196T3 (pt)
HU (1) HUP0102473A3 (pt)
IL (1) IL136462A0 (pt)
MY (1) MY137303A (pt)
NO (1) NO326832B1 (pt)
NZ (1) NZ504928A (pt)
PE (1) PE20000042A1 (pt)
PT (1) PT1041985E (pt)
SK (1) SK285584B6 (pt)
TW (1) TW581763B (pt)
WO (1) WO1999032114A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787327B1 (fr) * 1998-12-21 2003-01-17 Aventis Pharma Sa Compositions contenant des inhibiteurs de farnesyle transferase
PT1233787E (pt) * 1999-11-09 2005-04-29 Conseils Rech S Et D Applic Sc Produto contendo um inibidor da transducao dos sinais das proteinas g heterotrimericas em associacao com um outro agente anticanceroso para utilizacao terapeutica no tratamento do cancro
AU2292801A (en) * 1999-12-22 2001-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and methods for treatment of breast cancer
CA2397657A1 (en) * 2000-02-29 2001-09-07 Janssen Pharmaceutica Inc. Farnesyl protein transferase inhibitor combinations with platinum compounds
AU2001239275A1 (en) * 2000-02-29 2001-09-12 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
EP1263437A2 (en) * 2000-02-29 2002-12-11 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with vinca alkaloids
US20030186925A1 (en) * 2000-02-29 2003-10-02 Palmer Peter Albert Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
JP2003525244A (ja) * 2000-02-29 2003-08-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗腫瘍性アルキル化剤とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
AU2001244167A1 (en) * 2000-02-29 2001-09-12 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
TWI310684B (en) 2000-03-27 2009-06-11 Bristol Myers Squibb Co Synergistic pharmaceutical kits for treating cancer
AU2002236813A1 (en) * 2001-01-22 2002-07-30 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
WO2002064142A1 (en) * 2001-02-15 2002-08-22 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with antiestrogen agents
AU2002352941A1 (en) * 2001-11-30 2003-06-17 Schering Corporation Use of an farsenyl protein tranferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
WO2003047586A1 (en) * 2001-12-03 2003-06-12 Schering Corporation Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
CN105198758A (zh) * 2015-09-22 2015-12-30 湖南大学 一种高纯度(z)-他莫昔酚的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
JPH06504772A (ja) * 1990-12-18 1994-06-02 ザ　ウエルカム　ファウンデーション　リミテッド 抗癌剤の薬効を増強し抗多剤耐性を有する薬剤
JP2767176B2 (ja) * 1992-12-15 1998-06-18 大塚製薬株式会社 抗癌剤
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US6083985A (en) * 1995-08-09 2000-07-04 Banyu Pharmaceutical Co., Ltd. Medicinal composition
TW350844B (en) * 1995-12-22 1999-01-21 Schering Corp Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
CZ297979B6 (cs) * 1996-03-12 2007-05-16 Pg-Txl Company, L. P. Kompozice obsahující protinádorové lécivo konjugované s ve vode rozpustným polymerem, její pouzití pro výrobu léciva a implantovatelná lékarská pomucka
JP2000507584A (ja) * 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質転移酵素の阻害剤
CA2251716A1 (en) * 1996-04-15 1997-10-23 W. Gillies Mckenna Sensitization of cells to radiation and chemotherapy
JP2000513711A (ja) * 1996-04-18 2000-10-17 メルク エンド カンパニー インコーポレーテッド 癌の治療法
EP0934270A1 (en) * 1996-05-30 1999-08-11 Merck & Co., Inc. A method of treating cancer
WO1998032376A1 (en) * 1997-01-29 1998-07-30 Picker Medical Systems, Ltd. Predictive bolus tracking
NZ337283A (en) * 1997-02-18 2001-02-23 Canji Inc Use of a tumor suppressing nucleic acid which encodes wild type p53 or retinoblastoma proteins and paclitaxel derivative or a polyprenyl-protein transferase inhibitor for the treatment of neoplasms

Also Published As

Publication number Publication date
DK1041985T3 (da) 2006-06-19
PE20000042A1 (es) 2000-02-17
CO5080764A1 (es) 2001-09-25
DE69833509T2 (de) 2006-10-26
AU1907299A (en) 1999-07-12
HUP0102473A2 (hu) 2002-01-28
BR9814419A (pt) 2000-10-10
CA2315693A1 (en) 1999-07-01
JP2001526224A (ja) 2001-12-18
EP1041985B1 (en) 2006-02-15
KR100700907B1 (ko) 2007-03-29
AU756762B2 (en) 2003-01-23
SK8982000A3 (en) 2001-04-09
ES2255196T3 (es) 2006-06-16
NZ504928A (en) 2004-12-24
CL2007001889A1 (es) 2008-01-11
MY137303A (en) 2009-01-30
CZ298511B6 (cs) 2007-10-24
WO1999032114A1 (en) 1999-07-01
TW581763B (en) 2004-04-01
ATE317697T1 (de) 2006-03-15
JP4502503B2 (ja) 2010-07-14
SK285584B6 (sk) 2007-04-05
NO20003229L (no) 2000-08-22
DE69833509D1 (de) 2006-04-20
CA2315693C (en) 2010-11-30
NO326832B1 (no) 2009-02-23
CZ20002236A3 (cs) 2001-04-11
CN1284875A (zh) 2001-02-21
CN1129431C (zh) 2003-12-03
KR20010033452A (ko) 2001-04-25
NO20003229D0 (no) 2000-06-21
HUP0102473A3 (en) 2003-07-28
EP1041985A1 (en) 2000-10-11
AR017440A1 (es) 2001-09-05
IL136462A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
PT1041985E (pt) Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
BR9612203A (pt) Amidas tricíclicas úteis para a inibição da função da g-pro-teína e para o tratamento de doenças proliferativas
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
PT1073658E (pt) Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual
PT864327E (pt) Utilizacao de derivados de pirimidina para a preparacao de um medicamento para a prevencao do cancro
BR9604787A (pt) Compostos tricíclicos utilizáveis para inibição de função de proteína g e para tratamento de doenças proliferativas
PT948308E (pt) Metodos para o tratamento de pigmentacao da pele
BR9610248A (pt) Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto
EE200000379A (et) Amüloidogeense haiguse profülaktika ja ravi
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
BR9610733A (pt) Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
PT928193E (pt) Utilizacao de 1-hidroxi-2-piridonas para o tratamento de infeccoes da pele
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
EE200000333A (et) Eesnäärmevähi ravis kasutatav konjugaat ning farmatseutiline kompositsioon ja selle valmistamismeetod
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
PT1239862E (pt) Preparacao farmaceutica contendo citostaticos e aceitadores de electroes para o tratamento de cancro
PT1017388E (pt) Composicao farmaceutica contendo ibuprofeno e domperidona para o tratamento de enxaqueca
PT1231915E (pt) Uso de derivados de pleuromutilina para tratamento transdermal de doencas bacterianas